Research progress of TMED3 in malignant tumor
Author:
Affiliation:

1.Graduate School, Hebei Medicine University, Shijiazhuang 050017, China;2.Department of Gland Surgery, Hebei General Hospital, Shijiazhuang 050051, China;3.Graduate School, North China University of Science and Technology, Tangshan, Hebei 063210, China

Clc Number:

R73

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Transmembrane emp24 protein transport domain containing 3 (TMED3) is a member of the P24 protein family, which has become a biological research hotspot in recent years. Its abnormal expression is closely related to the biological behaviors of malignant tumors, such as cell proliferation, invasion, and migration. However, the specific mechanism of TMED3 in various tumors is very complicated. Here, the authors summarize the research status, mechanism, and clinical significance of TMED3 in malignant tumors, aiming to provide a reference for clinical and basic research of malignant tumors.

    Reference
    Related
    Cited by
Get Citation

HUO Jiaxing, ZHU Chunyue, SU Hang, LIN Xunyi, ZHANG Fenghua. Research progress of TMED3 in malignant tumor[J]. Chin J Gen Surg,2022,31(12):1680-1685.
DOI:10.7659/j. issn.1005-6947.2022.12.017

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:June 30,2022
  • Revised:October 11,2022
  • Adopted:
  • Online: January 08,2023
  • Published: